Anti-TNF therapy and malignancy - A critical review

被引:33
作者
Cohen, RB [1 ]
Dittrich, KA [1 ]
机构
[1] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA
来源
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2001年 / 15卷 / 06期
关键词
anti-tumour necrosis factor; cancer; Crohn's disease; etanercept; infliximab; lymphoma; malignancy; rheumatoid arthritis;
D O I
10.1155/2001/403102
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The roles of tumour necrosis factor (TNF) and anti-TNF ther apy in malignancy are reviewed, including an overview of baseline risk factors for malignancy in inflammatory diseases and the incidences of malignancies observed in clinical trials of an anti-TNF-alpha therapy, infliximab. The preclinical data and early clinical experience presented for infliximab do not provide evidence for a causal relationship between TNF a antagonism and the development of lymphoid or nonlymphoid cancers.
引用
收藏
页码:376 / 384
页数:9
相关论文
共 80 条
[2]  
Arancia G, 1990, Ann Ist Super Sanita, V26, P369
[3]   Disease activity and risk of lymphoma in patients with rheumatoid arthritis:: nested case-control study [J].
Baecklund, E ;
Ekbom, A ;
Sparén, P ;
Feltelius, N ;
Klareskog, L .
BRITISH MEDICAL JOURNAL, 1998, 317 (7152) :180-181
[4]  
Barak V, 1999, EUR J HAEMATOL, V62, P71
[5]  
Baxevanis CN, 2000, EUR J IMMUNOL, V30, P1957, DOI 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO
[6]  
2-7
[7]   Diagnosis of extraintestinal manifestations and cancers in IBD in large population-based databases. [J].
Bernstein, CN ;
Kliewer, E ;
Rawsthorne, P ;
Doig, W ;
Blanchard, JF .
GASTROENTEROLOGY, 1998, 114 (04) :A930-A931
[8]  
Bernstein D, 1996, AM J GASTROENTEROL, V91, P434
[9]  
Beutler B, 1992, TUMOR NECROSIS FACTO
[10]   The relationship between infliximab treatment and lymphoma in Crohn's disease [J].
Bickston, SJ ;
Lichtenstein, GR ;
Arseneau, KO ;
Cohen, RB ;
Cominelli, F .
GASTROENTEROLOGY, 1999, 117 (06) :1433-1437